ALPS Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-63,109
| Closed | -$2.13M | – | 1063 |
|
|
2021
Q2 | $2.13M | Sell |
63,109
-23,468
| -27% | -$793K | 0.02% | 315 |
|
|
2021
Q1 | $2.03M | Buy |
86,577
+721
| +0.8% | +$16.9K | 0.02% | 292 |
|
|
2020
Q4 | $2.47M | Buy |
85,856
+25,283
| +42% | +$728K | 0.03% | 245 |
|
|
2020
Q3 | $1.23M | Buy |
60,573
+3,505
| +6% | +$71K | 0.02% | 313 |
|
|
2020
Q2 | $1.72M | Sell |
57,068
-15,720
| -22% | -$472K | 0.02% | 253 |
|
|
2020
Q1 | $2.29M | Buy |
72,788
+5,210
| +8% | +$164K | 0.04% | 203 |
|
|
2019
Q4 | $3.18M | Buy |
67,578
+16,117
| +31% | +$759K | 0.02% | 190 |
|
|
2019
Q3 | $332K | Sell |
51,461
-2,539
| -5% | -$16.4K | ﹤0.01% | 798 |
|
|
2019
Q2 | $663K | Buy |
+54,000
| New | +$663K | ﹤0.01% | 477 |
|